AHA letter to the Health Resources and Services Administration about a new concerning development with the 340B Program.
Several updates were heard during a Feb. 24 meeting.
A new Ohio bill won't expand the 340B program, but it will protect patients' ability to fill prescriptions at their pharmacy of choice.
Minnesota hospitals and clinics participating in a controversial U.S. drug discount program reaped at least $1.34 billion in ...
The AHA March 3 urged the Health Resources and Services Administration to take immediate action to stop a new Novo Nordisk ...
A new report paints a stark picture of how a subset of large healthcare providers are drawing the lion’s share of 340B savings within a single state. | A Minnesota analysis of providers' reported ...
Feds back AbbVie Colorado 340B fight, arguing state law conflicts with federal 340B program in a key 10th Circuit appeal.
The 340B Drug Pricing Program entitles participating hospitals and clinics (called covered entities) to purchase outpatient drugs at a substantial discount from manufacturers. Covered entities either ...
Virginia state lawmakers who are tired of waiting are taking matters into their own hands during this year’s legislative ...
Claims by big hospital systems that the 340B Drug Pricing Program is “doing exactly what Congress intended” (“Comment: Hospitals staying true to Congress’ drug discounts,” The Herald, Feb. 14) ignore ...
The provision, tucked into a sprawling bill, would allow UConn to add behavioral health beds without going through state ...
HRSA extends comment period on 340B rebate proposal to April 20, allowing hospitals more time to submit detailed feedback.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results